正文
.
The value of medical device deals in the quarter was $37.4 billion, followed by $27.6 billion in deals in the healthcare services field. That high value in the medical device arena was driven largely by a couple large transactions, including Becton Dickinson’s $25.7 billion purchase of C.R. Bard in April as well as Medtronic’s $6.1 billion divestiture to Cardinal Health during the same month. The Becton Dickinson-C.R. Bard transaction alone represented almost one-third of the entire deal value for the healthcare sector, the Deals Insights report authors noted.
The third largest medical device deal was the purchase of The Spectranetics Corporation by Koninklijke Philips NV for $2.1 billion at the end of June. There were 18 transactions in the medical device space, according to the Deals Insights report. There were more transactions in the pharmaceutical space—29 deals—but the total value of these deals was $10.7 billion.
